Aeris Therapeutics, Inc.
Contact Us.
Improving the Lives of Patients with Lung Disease.

Aeris Therapeutics is engaged in the development and commercialization of novel therapies for patients with emphysema and other lung diseases.

Aeris Therapeutics lead product is the AeriSeal™ System for Lung Volume Reduction for the treatment of advanced emphysema.

Emphysema affects approximately 4 million patients in the United States and as many as 60 million patients worldwide. 

The AeriSeal™ System for Lung Volume Reduction
The Aeris BLVR System Demo.

CAUTION: The AeriSeal System for Lung Volume Reduction is an investigational device and is limited by Federal (or United States) law to investigational use.

Aeris Therapeutics
10K Gill Street
Woburn, MA 01801
Tel: 781.937.0110
Fax: 781.937.0077